Lack of vaccine causes Maxim to pull plug on flu shot clinics
COLUMBIA, Md. Citing a lack of availability, Maxim Health Systems, which operates flu shot clinics for a number of retailers, announced that it is canceling all remaining flu shot clinic programs. The move was effective Oct. 22.
“We apologize for any inconvenience this may have caused our customers and clients,” said Steve Pellito, national director of wellness for Maxim Health Systems. “This season has proven to be one of the most unique and unpredictable seasons of all time.”
According to Maxim, the focus around H1N1 vaccine production has caused vaccine makers to shift resources away from production of regular seasonal flu vaccine efforts. At the same time, heightened public awareness has led to unexpectedly high flu shot demand.
Schnuck exec honored by produce pub
ST. LOUIS A weekly newspaper serving the produce industry has given a top award to a Schnuck Markets executive.
The Packer named Schnucks VP produce and floral Michael O’Brien the 2009 “Marketer of the Year,” Schnucks announced, presenting him with the award at the Produce Marketing Association’s Fresh Summit earlier this month.
O’Brien has worked in the supermarket industry for 37 years, starting at Schnucks as a bagger in 1972, becoming a store manager in 1983 and division manager in 1990. He has served in his current position since 2001.
Schnucks said O’Brien had taken an “active role” in promoting produce consumption and was a member of a number of industry organizations. He is chairman-elect of the PMA’s board of directors and served as chairman of the Produce for Better Health Foundation in 2007, promoting that organizations “5 a day, Fruits & Veggies – More Matters” campaign to promote the eating of fruits and vegetables. Produce Merchandising magazine also named him “Retailer of the Year” in 2004.
AACE introduces diabetes algorithm
JACKSONVILLE, Fla. A new algorithm designed to help Type 2 diabetes patients achieve glycemic control has appeared online in the September/October edition of the journal Endocrine Practice.
The algorithm, released as a consensus statement by the American Association of Clinical Endocrinologists and the American College of Endocrinology is a one-page resource designed to assist primary care doctors, endocrinologists and others in the management of Type 2 diabetes.
“Depending on a patient’s current A1C level, a physician will use the algorithm to determine whether a mono-, dual- or triple-combination therapy should be considered,” former AACE president and co-chairwoman of the Algorithm Task Force Helena Rodbard said in a statement. “To minimize the risk of diabetic complications, the algorithm will help achieve a hemoglobin A1C value of 6.5 or less when appropriate.”
The task force said it was the first such algorithm that considers currently approved classes of medications emphasizing safety and efficacy while also considering factors such as the overall cost of care.